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ABSTRACT

The apolipoprotein E4 (apoE4) genotype is a major risk factor for Alzheimer's
disease (AD). Previous studies have shown that apoE4 is less effective than apoE3 in
supporting neurite outgrowth in adult mice cortical cultures. However the mechanism
underlying this phenomenon is not known. To understand this mechanism and the
broader role of apoE isoforms on neuronal biology I examined the rate of apoE isoforms
internalization in neurons, effects of apoE isoforms on lipid uptake by neurons, effects of
apoE isoforms on neuronal environment - microglia and on neuroregeneration, or
neurogenesis.
I examined the binding and internalization of recombinant human apoE3 and
apoE4 in cortical cultures derived from adult apoE knockout mice. The cultures were
incubated with apoE3 or apoE4 over various time periods at temperatures between 4°C
and 3 7°C before immunocytochemistry for apoE was performed. The data revealed that
cell-associated apoE3 uptake was significantly greater (:= 2.5 times) than apoE4
regardless of the incubation time; the percent of total immunoreactivity in the cell body
compared to dendritic immunoreactivity declined in the apoE3 group but did not change
in the apoE4 group primarily because of increased total apoE per neuron.
To determine the lipoprotein receptors that mediate the differential uptake of
apoE3 and apoE4 in neurons, I blocked the low-density lipoprotein (LDL) receptor
related protein (LRP) and cell surface heparan sulfate proteoglycans (HSPG). The data
revealed that inhibition of LRP decreased both apoE3 and apoE4 uptake. Blocking HSPG
totally inhibited uptake to undetectable levels. The data suggests that HSPG has a pivotal
role in apoE internalization.
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I predicted that apoE3 would deliver more lipids to neurons than apoE4 because the
rate of uptake of apoE3 was faster than apoE4 in neurons. To test this hypothesis, I
examined fluorescently labeled dodecanoic acid accumulation in adult cortical neurons.
Cells cultured with apoE3 internalized approximately twice as much vesicular
accumulations of fluorescence as those with apoE4. ApoE4 roughly doubled the amount
of lipid internalized compared to the absence of apoE. Therefore, although apoE4 was
better than no apoE, it was less effective than apoE3 in providing lipids.
Previous studies demonstrated that apoE regulates microglial activation and
inducible nitric oxide synthase (iNOS) in embryonic and postnatal mouse microglial
cultures. I examined and compared the effects of apoE3 and apoE4 on microglial
proliferation, morphology and activation in adult mouse cortical (AMC) and adult mouse
microglial (AMM) cultures. Microglial proliferation and morphology for each apoE
treatment in AMC and AMM cultures were assessed by immunocytochemistry; levels of
iNOS expression were assessed by immuno-blotting. The results from this study
demonstrated that apoE3 and apoE4 differentially regulate microglial proliferation and
activation and iNOS production in a neuron-microglia independent manner and apoE4
induces microglial proliferation and activation, when compared to apoE3.
Recent findings concerning the regenerative potential of the adult brain showed
that adult neurons have the ability to divide, a process known as neurogenesis. I
examined the effects of apoE3 and apoE4 on neurogenesis in AMC culture. Neuronal
proliferation in apoE3 or apoE4 treated cells was analyzed with MTT and BrdU cell
proliferation kits, followed by ELISA and immunocytochemistry. The results show that
the fraction of neurons in the DNA synthesis stage to total number of neurons in apoE3
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treatment was significantly higher than in apoE4 and apoE KO treatment groups. These
data suggests that apoE4 is less efficient in promoting neurogencsis. This study also
revealed new phenomenon of BrdU-positive satellite stain outside the BrdU-positive
nucleus in approximately 50% of dividing neurons. The significance of the satellite
BrdU-positive stain found in adult neurons in both apoE isoform treatment groups is yet
to be determined.
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1. INTRODUCTION

Apolipoprotein (apo-) E, a 34,000 kDa protein, exists in three maj1)r isoforms
(apoE2, apoE3 and apoE4) that are produced by three alleles (e2, e3 and e4, respectively)
at a single gene locus on chromosome 19 in humans [1]. The most common isoforn1,
apoE3, has cysteine and arginine at position 112 and 158, respectively [2].

Both

positions contain cysteine in apoE2 and arginine in apoE4. ApoE serves to distribute
lipids among tissues and cells by carrying the hydrophobic lipids and binding to
lipoprotein receptors on the cell surface [3]. Binding of apoE to the receptor results in
internalization of lipoproteins (lipids + apoE) by receptor-mediated endocytosis. Through
its function in transporting lipids among cells, apoE plays a critical role in lipid
metabolism within the body, including the CNS.
Recent findings demonstrate that inheritance of the e4 allele of apoE increases the
risk of Alzheimer's disease (AD) [4]. The mechanism by which apoE4 contributes to
AD is unknown.

Previous research has demonstrated that apoE3 promotes neurite

outgrowth in adult mouse cortical (AMC) neurons, whereas apoE4 inhibits neurite
outgrowth [5]. A better understanding of the pathway by which apoE isoforms enter the
cell and how they accumulate in neurons overtime was the aim of my first study on role
of apoE4 in AD.
I examined the binding and internalization of recombinant human apoE3 and

apoE4 in cortical cultures derived from adult apoE knockout mice. The data revealed
that cell-associated apoE3 was significantly greater

(~

2.5 times) than apoE4 regardless

of the incubation time. The percent of total immunoreactivity in the cell body compared
to dendritic irnmunoreactivity declined in the apoE3 group but did not change in the
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apoE4 group primarily because of increased total apoE per neuron. No significant
differences in cell associated apoE3 or apoE4 was detected in cultures incubated at 4°C.
To determine the lipoprotein receptor that mediates the differential uptake of
apoE3 and apoE4 in neurons, I blocked the low-density lipoprotein (LDL) receptor
related protein (LRP). The data revealed that inhibition of LRP with the receptor
associated protein (RAP) (5 µg/ml) and lactoferrin (LAC) (10 µg/ml) decreased both
apoE3 and apoE4 uptake. The role of heparan sulfate proteoglycans (HSPG), which are
necessary for the binding of apoE enriched lipoproteins to the cells prior to
internalization via the LRP, was examined by removing HSPG with heparinase (10
units/ml). Heparinase treatment totally inhibited uptake to undetectable levels. Uptake
inhibition by both RAP and LAC confirms the importance of the LRP in this response
and suggests that HSPG has a pivotal role in apoE internalization.
I predicted that apoE4 would deliver fewer lipids to neurons than apoE3 because
the rate of uptake of apoE4 was slower than apoE3 in neurons. To test this hypothesis, I
examined fluorescently labeled dodecanoic acid accumulation in adult cortical neurons.
Cells cultured with apoE3 internalized approximately twice as much vesicular fatty acid
as those with apoE4. ApoE4 roughly doubled the amount of lipid internalized compared
to the absence of apoE. Therefore, although apoE4 was better than no apoE, it was much
less effective than apoE3 in providing lipids.
Glia are present in significant numbers in the early stages of culture. This is important
to note, since previous data suggest that glia are a primary source of apoE [6]. To
identify glia, I previously [5] performed immunocytochemistry to label neurons

(~

tubulin), astroglia (glial fibrillary acidic protein) or lectin binding to label microglia
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(BSLl). At 3 days in vitro (DIV) I found that neurons comprise 70% of total cells.
astroglia 15% and microglia 15%.
Many recent studies have focused on the role of microglia in pathogenesis of AD
[7, 8, 9, 10,]. Results of several genetic studies showed a significant increase in amyloid
plaques in AD patients with allele e4 of apoE [11, 12] and that plaques in AD patients are
surrounded by activated microglia and reactive astrocytes [13]. Microglia respond to
damage or infection by proliferation and changing the morphology to macrophage-like
phagocytic cells [15]. Results from recent study have indicated that microglial activation
was induced in primary microglial cell cultures by factors contained in sera of AD-related
apoE 3/4 and apoE 4/4 genotypes [14]. However, previous studies used embryonic and
postnatal neuronal cultures to examine the effect of factors contained in sera of ADrelated apoE genotypes.
The aim of my next study was to determine the role of recombinant human apoE3
and apoE4 isoforms on cellular biology of microglia in two models: adult mouse cortical
culture (AMC) and adult mouse microglial culture (AMM). The questions this study
sought to answer were: (1) Do purified human apoE isoforms differentially effect
microglial number and activation in AMC culture? (2) Is this effect mediated via neuronglia interaction or do human apoE isoforms have a direct effect on microglial activation
and number?
Microglial activation is characterized by increase in microglial proliferation,
inducible nitric oxide synthase production and change in microglial morphology to
amoeboid phagocytic cells. ApoE KO adult mouse cortical (AMC) and apoE KO adult
mouse microglial (AMM) cultures were treated with recombinant human apoE3 and
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apoE4 (3 µg/ml), respectively, for 2 consecutive days, following by treatment with LPS
(100 ng/ml) to stimulate inducible nitric oxide synthase (iNOS) production in each apoE
treatment group. Microglial proliferation and morphology for each apoE treatment in
AMC and AMM cultures were assessed by immunocytochemistry; levels of iNOS
expression were assessed by immuno-blotting. The results from this study demonstrate
that (1) apoE KO AMC and AMM cultures have the highest number of microglia with
macrophage-like morphology and highest iNOS levels, when compared to apoE3 and
apoE4 treatments; (2) apoE3 and apoE4 differentially regulate microglial number,
activation and iNOS production; (3) apoE3 decreased microglial proliferation, activation
and iNOS production in both AMC and AMM cultures by nearly 60%, whereas apoE4 by
only 20%, as compared to apoE KO AMC and AMM cultures. These data show that
apoE isoforms regulate microglial proliferation and activation in a neuron-microglia
independent manner and apoE4 up-regulates microglial proliferation and activation, as
compared to apoE3.
Although the mammalian brain has long been thought to be entirely post mitotic,
the recent discoveries have confirmed an existence of adult neuronal division and neural
progenitor cells in various regions of the adult mammalian brain [16, 17, 18]. These recent
findings, concerning the regenerative potential of the adult brain, showed that
neurogenesis takes place in adult olfactory bulb, adult retina and the hippocampus. In the
past two years of my research, neurogenesis was observed in AMC cultures at 3 and 4
DIV.
In the present study I examined the effects of apoE3 and apoE4 on neurogenesis
in AMC culture. ApoE KO AMC cultures were treated with recombinant human apoE3

14

and apoE4 (3 µg/ml), respectively, for 2 consecutive days. On day 3 the number of cells
in AMC culture, treated with either apoE3 or apoE4 were analyzed by MTT cell
proliferation kit, followed by ELISA. The number of neurons was determined by
immunocytochemistry for neuron specific

~-tubulin.

The number of neurons in the stage

of DNA synthesis was determined by double immunocytochemistry with

anti-~-tubulin

and BrdU stain. Study of the effect of apoE3 and apoE4 on neurogenesis in AMC culture
showed that there was a significant difference in the number of neurons in the DNA
synthesis stage by day 4 in AMC culture. Percent of BrdU-positive neurons to total
number of neurons in the random field in apoE3 treatment was significantly higher than
percent of BrdU-positive neurons in apoE4 and apoE KO treatment groups. This study
also revealed new phenomena of BrdU-positive satellite stain in approximately 50% of
dividing neurons. The stain appears to correspond to an undifferentiated cell in the
dendritic tree or at perikaryon of a dividing neuron. The significance of the satellite
BrdU-positive stain found in adult neurons in both apoE isoform treatment groups

and

in apoE KO treatment should be further determined.

Based on the results from the four areas of my study, I propose that apoE4 is less
effective than apoE3 in binding and accumulating in neurons, delivering lipids to adult
neurons, suppressing microglial activation and promoting neurogenesis in adult brain.
Taken together, these data suggests that apoE4 may have several effects on adult neurons
and neuronal environment that lead to poor neuronal growth, repair, proliferation, thus
playing a possible role in age-related diseases including AD.
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2. METHODOLOGY

2.1. Materials

2.1.1. Adult mouse cortical culture and microglial cultures

Homozygous apoE KO mice (C57BL/6-Apoe<tmiUnc>, Cat. # 002052) bred 10
generations onto the C57BL/6 background were obtained from Jackson Laboratory (Bar
Harbor, ME). Cell culture medium, including Hibernate A (Cat.# 10740-025), Neurobasal
(Cat. # 21103-049), and B27 medium supplement (Cat. # 17504-010) were purchased
from Life Technologies Inc., (Gaithersburg, MD). Glutamine (Cat. # G-3126) and poly-Dlysine (Cat. # P-6407) were purchased from Sigma Chemicals (St. Louis, MO). Papain
(Cat.# 3119) was obtained from Worthington (Lakewood, NJ). Gentamicin (Cat.# 15710015), FGF2 (Cat. # 13256-029), and Optiprep (Cat. # 103-0061) were from Life
Technologies Inc., (Gaithersburg, MD). Twelve-millimeter glass cover slips (Cat. # P763-3029) were purchased from Carolina Biological (Burlington, NC). Falcon Brand 35
mm diameter dishes (Cat. # 08-772-4A) and Costar Brand Tissue Culture 24-well plates
(Cat.# 07-200-84) were purchased from Fisher Scientific (Chicago, IL).

2.1.2. lmmunocytochemistry for neurons. astrocytes and microglia

The mouse Anti-beta III Tubulin mAb (Cat. # G7121) was obtained from
Molecular Probes, mouse anti-Glial Fibrillary Acidic Protein (GFAP) (Cat. # N-3893),
and FITC- or TRITC-conjugated lectin from Bandeiraea simplicifolia (BSL-1) were
obtained from Sigma Chemicals (St. Louis, MO). The FITC- or TRITC-conjugated goat
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anti-mouse IgG-Fab2 specific (Cat. # 115-095-006) and normal goat serum (Cat. # 005000-121) were purchased from Jackson ImmunoResearch (West Grove, PA). Triton X100 (Cat. #T-9284) was purchased from Sigma Chemicals (St. Louis, MO). Antiphotobleach was purchased from Vectorshield Co.

2.1.3. Human ApoE

Human recombinant apoE3 (Cat. # P2003) and apoE4 (Cat. # P2004) were
purchased from Panvera (Madison, WI), and dialyzed overnight in O.lM ammonium
bicarbonate.

2.1.4. Immunocytochemistry tor apoE

Goat anti-human apoE (Cat. # 178479) was purchased from Calbiochem (San
Diego, CA). FITC-conjugated secondary antibody, and rabbit anti-goat IgG (Cat. # 305006-003) was obtained from Jackson ImmunoResearch (West Grove, PA).

2.1. 5. ApoE quantification

The monoclonal anti-apoE (3Hl) used for immunoprecipitation was obtained from
the University of Ottawa, Heart Institute. HRP conjugated secondary antibody, and rabbit
anti-goat IgG (Cat.# AP106P) was obtained from Chemicon (Temecula, CA). Protein ASepharose CL-4B (Cat. # P-3391) and BSA (Cat. # A-9418) were obtained from Sigma
Chemicals (St. Louis, MO). Goat anti-human apoE (Cat. # 178479) was purchased from
Calbiochem (San Diego, CA). All other materials used for apoE quantification, including
pre-cast 4-20% gradient gels (Cat. # FB3435), Millipore Immobilon-P Transfer
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Membranes (Cat. # IPVHOOOlO), Pierce SuperSignal West Pico Chemiluminescent
Substrate (Cat. # PI34080), Kodak Bio Max Light-2 film (5*7', Cat. # 05-728-53), Tris
(Cat.# BP154-l), Glycine (Cat.# BP381-l), SDS (Cat.# BP166-100), Tween 20 (Cat.#
BP337-500) and sodium bromophenol blue (Cat. # BP-114-25) were purchased from
Fisher Scientific (Chicago, IL).

2.1.6. LRP-HSPG inhibition

Heparinase I (Cat. # 51539) was purchased from and lactoferrin (Cat. # L9507)
was purchased from Sigma Chemicals (St. Louis, MO), RAP was kindly provided by Dr.
Dudley Stricklord from American Red Cross (MD).

2.1. 7. Fatty acid

4,4-difluoro-5-methyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoic

acid

(C 1-

BODIPY® 500/510 C 12) (Cat.# D-3823) was purchased from Molecular Probes (Eugene,
OR).

2.1.8. iNOS quantification

Bacterial lipopolysaccharide (LPS) from Salmonella typhimurium (Cat.# L9516) and
monoclonal anti-nitric oxide synthase inducible antibody (Cat. # N9657) was purchased
from Sigma Chemicals (St. Louis, MO). Horseradish peroxidase-conjugated goat antimouse IgG-Fab2 (Cat.# AP308P) was purchased from Chemicon (Temecula, CA).
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2.1.9. Cell proliferation and neurogenesis

Cell Proliferation Kit I (MTT-based) (Cat. # 1465007) and In Situ Cell
Proliferation Kit FLUOS (Cat. # 1810740) were obtained from Roche Applied Science
(Indianapolis, IN).

2.2. Methods

2.2.1 Adult mouse cortical culture

Techniques for the in vitro culture of neurons from adult mice were modified as
previously described [19]. For each experiment, a four-month-old mouse was
anesthetized with sodium pentobarbital (80 mg/kg). The entire cerebral cortex was
dissected from the rest of the brain in 2 ml B27/Hibernate A medium [B27/Hibernate A
with 0.5 mM glutamine] in a 35 mm diameter Petri dish at 4°C. The cortex was sliced
(0.5 mm thickness) and transferred to a 50 ml tube containing 5 ml B27/Hibernate A
medium. After warming for 8 min at 30°C, slices were digested with 6 ml of a 2 mg/ml
Papain solution in Hibernate A for 30 min at 30°C in a gyrating water bath to keep the
slices suspended. Slices were transferred to 2 ml B27/Hibernate A medium in a 15 ml
tube. After 2 min at room temperature, slices were triturated 10 times with a siliconized
9-inch Pasteur pipette, and allowed to settle for 1 min. Approximately 2 ml of the
supernatant was transferred to another tube, and the sediment resuspended in 2 ml
B27/Hibernate A medium. The above step was repeated twice, and a total of 6 ml
collected. The resultant supernatant was subjected to density gradient centrifugation at
800g for 15 min. The density gradient was prepared in four 1 ml steps of 35, 25, 20 and
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15% Optiprep in B27/Hibemate A medium (v/v). The fraction containing the neurons
was collected, and diluted in 5 ml B27/Hibemate A medium. After centrifuging twice at
200g for 2 min, the cell pellets were resuspended in 3 ml B27/Neurobasal A medium
[B27/Neurobasal A with 0.5 mM glutamine, no glutamate, 0.01 mg/ml gentamicin].
Suspended cells were counted in a hemacytometer, and 40,000 cells were plated in 50 µl
aliquots on glass cover slips (12 mm diameter) previously coated overnight with 100 µl
of 50 µg/ml poly-D-lysine in water. Following 1 hr incubation in a humidified incubator
at 37 °C and 5% C02 , cover slips were transferred to a 24-well plate containing 0.4 ml
B27/Neurobasal A medium. Cover slips were rinsed twice with B27/Hibemate A
medium, and then 0.4 ml growth medium [B27/Neurobasal A medium with 5 ng/ml
FGF2] was added to each well and the plate was further incubated. Neurite outgrowth,
and viability assays were performed after 4 days of incubation, as described below. For
culture periods greater than 4 days, half of the medium was replaced with
B27/Neurobasal A with 10 ng/ml FGF2 every four days.

2.2.2. Immunocytochemistry

Cells from 4-day old cultures were rinsed with warm PBS (37°C) and fixed with
4% paraformaldehyde in PBS for 20 min at room temperature. After rinsing twice with
PBS, cells were permeabilized with 0.5% Triton X-100 in PBS for 5 min. Cells were
rinsed again with PBS, and then blocked with 5% normal goat serum, 0.05% Triton X-100
in PBS for 1 hr. Cells were incubated at room temperature for 2 hours with anti-B-tubulin
1 µg/ml in PBS, or mouse anti-GP AP (1 :200) in the blocking solution. After rinsing four
times with PBS, cells were incubated with FITC-conjugated goat anti-mouse IgG-Fab 2
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(1 :200) in blocking solution for 60 min. Cells were washed four times in PBS, slips were
mounted in anti-photobleach medium (0.85 M n-propyl gallate, 60% glycerol in TBS).
Immuno-reactive cells were counted and digitally photographed on an Olympus BX50
microscope with appropriate fluorescence excitation filters.
For BSLl labeling of microglia, cells were fixed as described above, rinsed with
warm PBS, and incubated with fluorescein conjugated BSL 1 (1: 100 dilution) for 30 min
at room temperature. Following incubation the cells were rinsed with PBS, and fixed with
4% paraformaldehyde in PBS for 5 min. After rinsing in PBS, slips were mounted with
anti-photobleach and immuno-fluorescence was evaluated by fluorescence microscopy
using 400x and 1OOOx magnification.

2.2.3. ApoE and apoEIB-tubulin immunocytochemistry

At 3 DIV growth medium was removed and only 200 µl of the medium was
replaced. Cells were incubated for 1 hour at 37°C in the humidified incubator with 5%
C02. ApoE3 and apoE4 isoforms of human apoE were added to the wells to reach final
concentration of 3 µg/ml. Cells were incubated for 5, 15, 30 and 60 minutes in the
incubator at 37°C and for 60 minutes at 4°C. No ApoE was added to the control wells.
Following the incubation with apoE3 and apoE4, cover slips were rinsed 3 times with
37°C T-TBS (20 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 7.5) and then
washed in T-TBS three times for 5 min. Cover slips were washed with 30% ethanol in TTBS for 10 min and fixed in 80% ethanol for 1 hour at room temperature. Cover slips
were rinsed again with T-TBS 3 times, permeabilized with 0.5% Triton X-100 in T-TBS
for 30 min and rinsed 3 times with T-TBS. Non-specific blocking was performed using
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1% BSA, 15% apoE KO mouse serum in T-TBS for 1 hour and l 0 minutes at room
temperature, after which cover slips were rinsed 3 times in T-TBS. Cells were incubated
with primary antibody (anti-apoE human, goat) 1:200 in T-TBS at room temperature for
2 hours and then rinsed with T-TBS, washed 3 times for l 0 minutes in T-TBS and rinsed
once more. Cells were incubated with secondary antibody (FITC conjugated donkey antigoat), 11200 in T-TBS for 30 min at RT, in the dark. Cover slips were finally rinsed with
T-TBS, washed 3 times in T-TBS for 5 min and washed again 2 times for 5 minutes in
distilled water, covered from light and mounted on the microscope slide with antiphotobleach. Double immunocytochemistry for apoE and P-tubulin was performed by coincubation with anti-apoE human, goat, 1:200 and 1 µg/ml anti-P-tubulin in PBS for 2
hours at RT; followed by FITC conjugated donkey anti-goat 1:200 for 30 min and TRITC
donkey anti-goat 1:200 for 50 minutes. Cover slips were mounted with anti-photobleach
and sealed. Immuno-fluorescence was evaluated by fluorescence microscopy using 400x
magnification.

2. 2. 4. Fatty acid immunocytochemistry
At 3 DIV AMC culture was co-incubated with 4,4-difluoro-5-methyl-4-bora-3a,
4a-diaza-s-indacene-3-dodecanoic acid (1 Oµg/ml) and apoE3 or apoE4 (3 µg/ml) for 1 hr
in humidified atmosphere (3 7°C, 5% C02). Cells were washed 3 times with warm PBS
and the cover slips were mounted in PBS on microscope slides. Immuno-fluorescence
was evaluated by fluorescence microscopy in live cells using 1OOx objective.
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2.2.5. Adult mouse microglial culture

The cells were initially prepared as described above in Methods 2.2.1. including the
first density gradient spin step. The density gradient separates the cortex into cell layers,
where microglia can be found at the bottom of the tube in the form of a small pellet [ 19].
After the density gradient spin as described in Methods 2.2.1, the pellet was collected and
spun twice with 5 ml of B27/Hibernate A medium. Cells were resuspended in 1 ml of
B27/Neurobasal A medium, counted in a hemacytometer, and 40,000 cells were plated in
150 1 aliquots on untreated glass cover slips (12 mm diameter) for 30 minutes in a
humidified incubator at 37 °C and 5% C02. Then cell were gently rinsed once with warm
B27/Neurobasal A medium and 0.4 ml growth medium [B27/Neurobasal A medium with
5 ng/ml FGF2] was added to each well and the plate was further incubated.

2. 2. 6. Stimuli

Bacterial lipolysaccharide (LPS) from Salmonella typhimurium was used to stimulate
inducible nitric oxide synthase (iNOS) production by activated microglia in AMC and
AMM cultures. LPS was resuspended in sterile PBS at 10 mg/ml and was added to AMC
culture medium at final concentration of 100 ng/ml on 4 DIV, 12 hours prior to fixing.

2.2. 7. iNOS quantification

Cell medium from 3 wells (1200 µl) per apoE treatment from 4-day-old AMC
cultures was collected and centrifuged to eliminate suspended cells. iNOS was
immunoprecipitated by incubating the supernatant with 1.2 µl of monoclonal anti-NOS
antibody on ice for 1 hour. Following incubation, 12 µl of 10% protein A-Sepharose CL4B was added, and the medium was further incubated on ice for 1 h on a shaker. The
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medium was centrifuged at 10 000 g for 15 min at 4 °C and the supernatant discarded.
The pellet was boiled for 5 min in 2x Lammeli sample buffer and electrophoresed on 420% SDS-polyacrylamide gradient gels in EC120 Mini gel vertical system. The samples
were run at 80 V until separation began, and then at 120 V until the dye front neared the
bottom of the gel.
Following electrophoresis, the gel was placed in transfer buffer (3.03 g Tris base,
14.4 g glycine, 200 ml methanol, 800 ml distilled H20, pH 7.6) on a shaker for 10 min.
The transfer membrane, Millipore Immobilon-P Transfer Membrane, was first soaked in
methanol for 5 s and then washed in distilled H20 for 5 min to remove excess methanol.
The proteins in the gel were transferred to the Immobilon-P membrane using a Bio-Rad
Trans-blot Transfer Cell following the manufacture's protocol.
Blots were blocked in PBS buffer with 3% dry non-fat milk for 20 min at room
temperature on a shaker. The blots were incubated with monoclonal anti-NOS inducible
antibody 1: 1000 in PBS buffer with 3% day non-fat milk on a shaker at 4 °C overnight.
Then blots were washed 6 times (10 min each) in TBS-T buffer (20 mM Tris-HCl, 150
mM NaCl, 0.05% Tween 20, pH 7.5). Blots were then incubated in HRP-conjugated goat
anti-mouse IgG 1:2 000 dilution in PBS buffer with dry non-fat milk for 1.5 hon a shaker
at room temperature, washed 6 times (10 min each) with TBS-T buffer, incubated with
Pierce SuperSignal West Pico Chemiluminescent Substrate, and then exposed to Kodak
BioMax Light-2 film. A 130-kDa band were visualized which is consistent with the
published molecular weight of NOS. Bands were quantified by densitometry (Scion
Image, MD, USA).
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2.2.8. Cell proliferation and ELISA

The assay is based on the cleavage of the yellow tetrazolium salt MTT to purple
formazan crystals by metabolic active cells. The formazan crystals formed are solubilized
and the resulting colored solution is quantified using a scanning multiwell
spectrophotometer (ELISA reader). AMC cultures was grown in 100 µl of Neurobasal A
supplemented with B27 in a 96 well tissue culture plates. At 3 DIC the MTT labeling
reagent 0.5 mg/ml was added to each well. The plates were incubated for 4 h in a
humidified atmosphere (37°C, 5% C02). Solubilization solution (20 µl) was then added
into each well. Plates were incubated overnight in a humidified atmosphere (37°C, 5%
C02). Spectrophotometrical absorbance of the samples was measured using a microtiter
plate (ELISA) reader at 562 nm.

2. 2. 9. BrdUIB-tubulin immunocytochemistry

At 3 DIV 40 µl of BrdU labeling solution was added to the culture medium
containing no FGF and cells were incubated for 60 min at 37°C in a humidified
atmosphere (5% C02). The cover slips were washed 3 times in PBS and fixed with the In
Situ Proliferation Kit FLOUS kit fixative solution for 45 min at RT. Cover slips were
then washed 2 times in PBS, 2 x 2 min, at RT and incubated in denaturation solution (4
M HCl) for 20 min, at RT. Cells were neutralized in PBS 3x5 min, followed by
incubation with the kit incubation buffer pH for 15 min at RT and incubation with 10
µg/ml

anti-~-tubulin

in PBS for 1 hour at RT. Cells were then incubated with 50 µl of

anti-BrdU-FLUOS antibody combined with 1:200 donkey anti-mouse at 37°C for 1 hour
and then rinsed 3 times in PBS at RT. Cover slips were mounted in PBS and sealed.
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Immuno-fluorescence was evaluated hy fluorescence microscopy usmg

1OOOx

magnification.

2.2.10. Microscopy and imaging

Immunocytochemistry was visualized with appropriate fluorescence excitation
filters for fluorescent microscopy (Olympus BX-50). Tiff format images of 30 random
fields per cover slip were taken with a Pixera digital camera for microscopy at identical
manual exposure setting for all experiments within each study. Fluorescence was
measured by quantifying mean optical fluorescence of each image using Scion Image
software with a 256 bit deep camera. The upper and lower 20 bits were cut off to
eliminate non-specific fluorescence and a mean density of pixels/field within this range
were obtained. The data were normalized for readings between 0 and 100 for statistical
analysis, using the following formula:
[(Pixels x mean pixels) I (number of cells per random field of view)] /10,000

2.2.11. Statistical analysis

All experiments were repeated 3-5 times using different preparations of adult mouse
cortical neurons, microglia and reagents. The data in individual experiments were
presented as meanD±standard error and statistical analysis was performed using SPSS
statistical software.
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3. RESULTS

3.1. Characterization of adult mouse cortical culture
The three cell types in the AMC culture were identified by immunocytochemistry.
The majority of the cell (approximately 70%) was neurons staining positive for P-tubulin
(Fig. 1). Astroglia, staining with anti-GF AP and microglia staining with BSL 1 were
present in equal proportions, approximately 15% each (Fig. 1). These three markers
identified an average of 97% of the viable cells present in a three-day old culture.
Representative morphologies of immuno-stained cells are shown in Fig. 2. P-tubulin
immuno-reactive cells displayed several long processes with branches. GF AP positive
cells had shorter processes with many branches. Microglial cells were either branched or
round, with numerous fine processes, known as cilia.
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Figure 1. Immuno-fluorescent labeling of cell types in the adult mouse cortical
culture. For each antigen, 6 cover slips were immuno-stained, and immuno-positive
cell in 30 fields/slip were counted and expressed as a percentage of total viable cells.
Values represent fraction of each cell type in AMC culture. Data are mean±S.E.M,
p<0.05.

Figure 2. Representative morphologies of three cell types in AMC culture: neurons
stained for P-tubulin, astrocytes stained for GFAP and microglia stained with BSLl.
Fluorescent microscopy, lOOOx magnification. Scale bar=lO µm.

28

3.2. Accumulation ofapoE3 and apoE4 in AMC neurons
The cell-associated apoE3 was significantly (Repeated Measures ANOVA, F=2,
df=78.738, p<0.01) greater than apoE4 at all time courses at 37°C: at 5, 15, 30 and 60
minutes. At 4°C cell-associated apoE3 was significantly (Repeated Measures ANOVA,
F=2, df=l,78.738, p<0.01) lower than apoE4 (Fig. 3,4). Immunoreactivity was primarily
of a punctuate nature. Experiment was repeated 3 times with different cell cultures and
reagents, 80 neurons were analyzed per treatment, per time course, per experiment.
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Figure 3. Quantification of accumulation of apoE3 and apoE4 in AMC neurons at
5, 15, 30 and 60 minutes at 37°C and at 60 minutes at 4°C. Values represent neuronassociated apoE3 and apoE4 at each time point and temperature, mean±S.E.M.
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Figure 4. Accumulation of apoE3 and apoE4 in AMC neurons. Left column: apoE3.
Right column: apoE4. A-H: incubation at 37°C. (A,B) apoE3 and apoE4
accumulation at S min. (C,D) at 15 min. (E,F) at 30 min. (G,H) at 60 min. (I,J) at 60
minutes at 4°C. Fluorescent microscopy, lOOOx magnification. Scale bar=lO µm.
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3.3. Accumulation ofapoE3 amJ_qp_oE4 in somata and dendrites
Analysis of immuno-fluorescence in apoE3 and apoE4 treatment groups at 5, 15,
30 and 60 minutes at 37°C and at 60 minutes at 4°C revealed that significantly (Repeated
Measures ANOVA, F=2, df=l,78.738, p<0.01) more of apoE3 and apoE4 accumulated in
somata than dendrites (Fig. 5,6). However, at all time points at 37°C, apoE3 level in
dendrites was 30 or above, as measured in pixels of immuno-stain fluorescence, whereas
accumulation of apoE4 in dendrites was below 10 pixels (Fig. 5,6).
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Figure 5. Quantification of accumulation of apoE3 in somata and dendrites in AMC
neurons at 5, 15, 30 and 60 minutes at 37°C and at 60 minutes at 4°C. Values
represent soma-associated and dendrite-associated apoE3 at each time point and
temperature, mean±S.E.M.
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Figure 6. Quantification of accumulation of apoE4 in somata and dendrites in AMC
neurons at 5, 15, 30 and 60 minutes at 37°C and at 60 minutes at 4°C. Values
represent soma-associated and dendrite-associated apoE4 at each time point and
temperature, mean±S.E.M.

Experiment was repeated 3 times with different cell cultures and reagents, 80
neurons were analyzed per treatment, per time course, per experiment.

3.4. Accumulation of apoE3 and apoE4 following inhibition of LRP-HSPG receptor
complex
To test my hypothesis that apoE3 and apoE4 differential accumulation is mediated
by LRP-HSPG receptor complex, I used LRP and HSPG inhibitors and analyzed apoE3
and apoE4 accumulation following the inhibition of LRP or HSPG. Pretreatment of apoE
KO AMC neurons with known LRP receptor inhibitors RAP (5 µg/ml) and lactoferrin
(10 µg/ml) [20] for 1 hour prior to incubation with apoE3 and apoE4 significantly
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(MAN OVA, df=3,89, p<0.01) decreased accumulation of apoE3 and apoE4, retaining the
same significant difference in accumulation between apoE3 and apoE4 as was observed
in the control group without LRP inhibitors (Fig. 7,8). Pretreatment of apoE KO AMC
neurons with a known HSPG inhibitor heparinase I (10 units/ml) for 1 hour prior to
incubation with apoE3 and apoE4 has shown that removal ofHSPG completely abolished
the difference between apoE3 and apoE4 and inhibited internalization of both apoE3 and
apoE4 to undetectable amounts (Fig. 7,8). The experiment was repeated 3 times; images
of 30 neurons were analyzed per apoE treatment, per inhibitor treatment, per experiment.
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Figure 7. Quantification of accumulation of apoE3 and apoE4 in apoE KO AMC
neurons at 1 hour, following the pretreatment of neurons with LRP receptor
inhibitors RAP and lactoferrin, and with HSPG receptor inhibitor heparinase I.
Values represent neuron-associated apoE3 and apoE4 for each inhibitor treatment,
mean±S.E.M.
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Figure 8. Accumulation of apoE3 and apoE4 in apoE KO AMC neurons at 1 hour,
following the pretreatment of neurons with LRP-HSPG receptor complex inhibitors.
Left column: apoE3. Right column: apoE4. (A,B) apoE3 and apoE4 accumulation in
the absence of LRP-HSPG inhibitors. (C,D) apoE3 and apoE4 accumulation
following pretreatment with RAP; (E,F) with lactoferrin; (G,H) with heparinase I.
Fluorescent microscopy, lOOOx magnification. Scale bar=lO µm.
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3.5. Effect ofapoE3 and apoE4 on fatty acid transport irt AMC culture
I predicted that apoE4 would deliver fewer lipids to neurons than apoE3 because the
rate of uptake of apoE4 was slower than apoE3 in AMC neurons. To test this hypothesis,
I examined fluorescently labeled dodecanoic acid accumulation in adult cortical neurons.
AMC neurons cultured with apoE3 internalized approximately twice as much vesicular
accumulations of fluorescence as those with apoE4 (Univariate ANOVA, Bonferroni ttest, df=2,89, p<0.01). Post hoc t-testing showed that E3>E4>KO (no apoE) for total
lipid uptake (Fig. 9). ApoE4 roughly doubled the amount of lipid internalized compared
to the absence of apoE (Fig. 10). Therefore, although apoE4 was better than no apoE, it
was much less effective than apoE3 in providing lipids. The experiment was repeated 3
times; the images of 30 neurons were analyzed per apoE treatment, per experiment.
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Figure 9. Percent of fluorescent fatty acid accumulation facilitated by apoE3 and
apoE4 of fluorescent fatty acid accumulation in apoE KO AMC neurons at 1 hour
after incubation. Values represent mean±S.E.M.
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Figure 10. Fluorescence intensity of the fatty acid (BODIPY-FL) at 1 hour after
incubation with apoE isoforms or in the absence of apoE (KO). (A) fatty acid
accumulation without apoE; (B) fatty acid accumulation when co-incubated with
apoE3; (C) with apoE4. Of note: apoE4 is better than no apoE. Fluorescent
microscopy, lOOOx magnification. Scale bar=lO µm.

3.6. Effect ofapoE3 and apoE4 on microglial proliferation and morphology in AMC
culture

ApoE isoforms play an important role in both neuronal biology and neuronal
environment. Based on previous studies on the differential effect of apoE3 and apoE4
peptides on microglial number and morphology and activation [14, 21] in embryonic and
postnatal neuronal cultures, I proposed and tested the hypothesis that apoE3 and apoE4
differentially regulate microglial number, morphology and activation in AMC culture. I
compared effects of human apoE3 and apoE4 on microglial number in apoE KO AMC
cultures. AMC cultures treated with human apoE4 had significantly (Univariate ANOVA,
Bonferroni t-test, df=2,89, p<0.01) higher number of microglia per field than apoE3
treatments, in total of 90 fields per treatment analyzed (Fig. 11). The highest microglial
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number per field was observed in the absence of apoE (KO) (Fig. 11 ). ApoE KO cultures
had on average approximately 13 microglia per 200 µm 2 , whereas apoE4 treatment group
had on average 11 microglia per 200 µm 2 and apoE3 treatment group had only 9
microglia (Fig. 11 ).
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Figure 11. Effect of human apoE3, apoE4 and absence of apoE (KO) on microglial
proliferation in apoE KO AMC culture. Values represent mean±S.E.M.

As previous studies have shown, microglia respond to damage or infection by
proliferation and changing the morphology to macrophage-like phagocytic cells [15]. In
all three apoE treatment groups significant (Univariate ANOVA, Bonferroni t-test,
df=2,89, p<0.01) impact on microglial morphology was observed. ApoE KO and apoE4
groups were represented by 76% and 50% macrophage-like microglia, respectively,
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whereas apoE3 group had only 20% of macrophage-like microglia (Fig. 12, 13). The
experiment was repeated 3 times, morphology of microglia in 30 fields (10 fields per
cover slip) were analyzed per apoE treatment, per experiment.
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Figure 12. Effect of human apoE3, apoE4 and absence of apoE (KO) on microglial
morphology in apoE KO AMC culture. Values represent percent of macrophage
microglia in each treatment group, mean±S.E.M.

38

~--

1

Fig. 13. Effect of apoE isoforms and absence of apoE on microglial morphology in
adult mouse cortical culture. Top row: immuno-positive cells under 60x objective.
(A), AMC culture microglia incubated with apoE3 have structured ciliated
morphology. (B), AMC culture microglia incubated with apoE4 have macrophage
morphology. (C), apoE KO AMC culture microglia are predominantly macrophagelike. Scale bar=lO µm. Bottom row: immuno-positive cells under lOOx objective. (D),
representative morphology of AMC culture microglia when treated with apoE3, (E),
representative morphology of AMC culture microglia when treated with apoE4, (F),
morphology of AMC culture microglia in the absence of apoE. Scale bar=lO µm.

3. 7. Effect of apoE3 and apoE4 on microglial proliferation and morphology in adult
mouse microglial (AMM) culture

To determine whether human apoE3 and apoE4 have a direct effect on adult mouse
microglial number and morphology in the absence of neurons and astrocytes, I prepared
pure microglial (99.5%) adult mouse cultures as described in Methods. Like AMC
cultures, microglial cultures were treated with 3 µg/ml of human apoE3 and apoE4 at 2
and 3 DIV, and then fixed on day 4 to assess the cell proliferation and morphology. In
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apoE4 treatment group microglial number was significantly (Univariate ANOVA,
Bonferroni Hest, df=2,89, p<0.01) higher than in the apoE3 group (Fig. 14). The highest
number of cells per field was observed in the apoE KO group (Fig. 14). The pattern of
cell proliferation due to apoE isoforms treatments in AMM cultures was very similar to
microglial proliferation in AMC cultures treated with apoE3 and apoE4 (Fig. 11, 14). The
data show that apoE3 and apoE4 can have a direct impact on the morphology of adult
microglia and that treatments with apoE4 result in a higher number of adult microglia
with predominant macrophage morphology. The experiment was repeated 3 times,
morphology of microglia in 30 fields (10 fields per cover slip) were analyzed per apoE
treatment, per experiment.
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Figure 14. Effect of human apoE3, apoE4 and absence of apoE (KO) on microglial
proliferation in apoE KO AMM culture. Values represent mean±S.E.M.
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Morphological study of AMM cultures showed that apoE isoforms have a
significantly (Univariate AN OVA, Bonferroni t-test, df=2,89, p<0.01) different effect on
microglia in the absence of neuron-microglia and astocyte-microglia interactions, and
that this effects is similar to the one observed in AMC culture. ApoE KO group had the
highest percentage (76%) of macrophage microglia, followed by apoE4 group at 58% and
apoE3 group at 34% (Fig. 15, 16). These data show that apoE4 and the absence of apoE
up-regulate cell number in AMM cultures, just as they do in AMC cultures.
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Figure 15. Effect of human apoE3, apoE4 and absence of apoE (KO) on microglial
morphology in apoE KO AMM culture. Values represent percent of microphage
microglia in each treatment, mean±S.E.M.
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Figure 16. Effect of apoE isoforms and absence of apoE on morphology in adult
mouse microglial culture. Top row: immuno-positive cells under 60x objective; (A)
AMM culture incubated with apoE, (B) AMM culture incubated with apoE4, (C)
apoE KO AMM culture. Scale bar=lO µm. Bottom row: immuno-positive cells under
lOOx objective. (D, Representative morphology of AMM culture microglia treated
with apoE3, (E) Representative morphology of AMM culture microglia treated with
apoE4, (F) in the absence of apoE (apoE KO). Scale bar=lO µm.

3.8. E ffect of apoE3 and apoE4 on iNOS production in AMC culture
To determine whether predominant macrophage morphology of microglia in apoE4
and apoE KO groups is correlated with microglial activation, I measured the inducible
nitric oxide synthase (iNOS) production by microglia in AMC culture. LPS, a classic
neuroinflammatory stimulus was added 12 hours before fixing. I examined iNOS levels
in apoE3, apoE4 and no apoE treated AMC culture cell medium at 4 DIV by immunoblotting as described in Methods. A significantly (Univariate ANOVA, Bonferroni t-test,
df=2,2, p<0.02) elevated level of iNOS was detected in apoE KO AMC culture cell
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medium (Fig. 17, 18). These data indicate that the absence of apoE results in the highest
level of microg]ial activation in AMC culture when compared to apoE3 and apoE4.
Presence of apoE4 resulted in significantly higher microglial activation than of apoE3
treatment in AMC cultures (Fig. 17, 18). Cell medium was collected from 3 wells per
apoE treatment, per experiment.
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Figure 17. Quantification of iNOS levels in apoE3, apoE4 treated AMC culture and
apoE KO culture by Western Blotting. Values represent mean±S.E.M.
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Figure 18. Effect of apoE3, apoE4 and absence of apoE (KO) on iNOS production
by AMC culture microglia: (A) growth medium without cells, (B) medium from
apoE3 treated cells, (C) apoE4 treated cells, (D) apoE KO cells.

3.9.

Effect of apoE3 and apoE4 on neurogenesis in AMC cultures
Based on the previous findings on neurogenesis in adult brain [16] and my

observations of neurogenesis in AMC cultures, I proposed that apoE3 and apoE4 might
have differential effect on neurogenesis in AMC culture. To test this hypothesis, AMC
cultures were treated with human apoE3 and apoE4 at 2 and 3 DIV. At 4 DIV total cell
proliferation was assessed by MTT cell proliferation kit and ELISA. No significant
(Univariate ANOVA, Bonfeffoni t-test, df=2,11, p>0.05) difference in cell number
between apoE3, apoE4 and no apoE (KO) treatments was detected (Fig. 19). The
experiment was repeated 3 times, absorbance values from 12 wells per apoE treatment,
per experiment (using 96-well microtiter plates) were analyzed and compared.
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Figure 19. Effect of apoE3, apoE4 and absence of apoE (apoE KO) on cell
proliferation in AMC culture at 4 DIV. Values represent mean±S.E.M.

Since AMC culture is represented by three cell types (Results 3.1.) and microglial
proliferation is higher in apoE4 and apoE KO than in apoE3 treated cells by 4 DIV
(Results 3.6.), my next aim was to determine the number of neurons by neuron specific Ptubulin immunocytochemistry in apoE3, apoE4 and apoE KO AMC cultures and compare
the number of neurons between these treatments at 4 DIV. AMC cultures were treated
with 3 µg/ml of human apoE3 and apoE4 at 2 and 3 DIV. At 4 DIV cells were fixed,
immuno-stained for P-tubulin and counted in 30 random fields per cover slip. The count
showed E3>E4>KO for average number of neurons per field, but no significant
(Univariate ANOVA, Bonferroni t-test, df=2,89, p>0.05) difference in the number of
neurons between apoE3, apoE4 and no apoE (KO) treatments was detected by Post Hoc
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testing (Fig. 20). The experiment was repeated 3 times, 30 fields (10 fields per cover slip)
were analyzed per apoE treatment, per experiment.
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Figure 20. Effect of apoE3, apoE4 and absence of apoE (apoE KO) on proliferation
of neurons in AMC culture at 4 DIV. Values represent mean±S.E.M.

To determine if a slight but not significant difference in neuron number in AMC
culture at 4 DIV in apoE3, apoE4 and apoE KO treatments accounts for neurogenesis, I
treated apoE KO AMC cultures with 3 µg/ml of human apoE3 and apoE4 at 2 and 3 DIV,
fixed cells and performed double immunocytochemistry for

~-tubulin

and BrdU. Since it

has been shown that 5-bromo-2 '-deoxyuridine (BrdU), a thymidine analogue, shares S
phase labeling characteristics with [3H]-thymidine, immunochemical detection of BrdU
incorporation into DNA has become a powerful tool for identifying cells in which DNA
synthesis has occurred. In apoE3, apoE4 and apoE KO treatments BrdU stain was picked
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up by many non-neuronal cells (Fig. 21, A) determined by their non-specificity to

B-

tubulin (Fig. 21,B).

Figure 21. (A) BrdU-positive cell of non-neuronal origin in AMC culture at 4 DIV.
(B) BrdU-negative neuron in AMC culture at 4 DIV. Fluorescent microscopy, lOOOx
magnification. Scale bar=lO µm.

However, a number of BrdU-positive neurons were detected in apoE3 , apoE4 and
apoE KO treatment groups (Fig. 22).
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Figure 22. BrdU-positive neurons in AMC culture at 4 DIV treated with (A ) apoE3;
(B) apoE4; (C) no apoE (KO). Fluorescent microscopy, lOOOx magnification. Scale
bar=l O µm.

A significantly (Univariate ANOVA, Bonferroni t-test, df=2,89, *p<0.0 1) higher
number of BrdU-positive neurons were detected in apoE3 treatment group than in apoE4
or apoE KO (Fig. 23). Post Hoc testing showed no significant (Univariate ANOVA,
Bonferroni t-test, df=2,89, **p>0.05) difference between the number of BrdU-positive
neurons in apoE4 and apoE KO (Fig. 23). The experiment was repeated 3 times, 30 fields
(10 fields per cover slip) were analyzed per apoE treatment, per experiment.
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Figure 23. Effect on apoE3, apoE4 and no apoE (apoE KO) on neurogenesis in
AMC culture at 4 DIV. Values represent mean±S.E.M.

3.10. BrdU-positive satellite stain phenomenon in BrdU-positive neurons
In approximately 50% of BrdU-positive neurons in apoE3, apoE4 and apoE KO
treatment groups a BrdU-positive satellite staining was detected. This staining did not
correspond to debris of stain clusters. It appeared to correspond to a cell body of
undifferentiated cell and was located in a dendritic tree or at a terminal bouton or at
perikaryon of a neuron. Fluorescent and bright field microscopy with 1OOx objective
shows the satellite cell body and incorporation of BrdU stain in a satellite cell (Fig. 24).
BrdU-positive satellite cells were detected in all three experiments (Results 3.10); 30
fields (10 fields per cover slip) were analyzed per apoE treatment, per experiment.
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Figure 24. Image of BrdU-positive AMC neuron at 4 DIV with BrdU-positive
satellite stain along a dendrite taken with (A) Fluorescent filter, lOOx objective; (B)
Bright field microscopy, lOOx objective. Scale bar=lO µm.
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4. DISCUSSION

Important previous research on the differential effect of apoE3 and apoE4 on
neurite outgrowth of adult neurons [5] suggested a mechanism by which apoE may lead
to AD. That study showed that apoE3 increases neurite outgrowth in AMC neurons,
whereas apoE4 inhibits neurite outgrowth. In the present recent study I investigated a
possible mechanism by which apoE4 inhibits neurite outgrowth in adult neurons by
comparison of (1) apoE3 and apoE4 accumulation rate in the neurons and (2) in somata
and dendrites, (3) apoE3 and apoE4 binding rate to apoE receptor complex on neuronal
membrane surface and (4) apoE3 and apoE4 rate of lipid transport. I also investigated (6)
the roles of apoE3 and apoE4 on neuronal proliferation (neurogenesis) and (5) their roles
on neuronal environment - microglia.
Results of my studies show (1) apoE3 and apoE4 differentially accumulate in
AMC neurons; (2) differential binding of apoE3 and apoE4 in AMC neurons is mediated
by HSPG receptor of LRP-HSPG receptor complex; (3) apoE3 and apoE4 differentially
transport lipid to AMC neurons; (4) apoE3 and apoE4 have a differential effect on
microglial number, morphology and activation in both AMC and AMM cultures and (5)
apoE3 and apoE4 have a differential effect on neurogenesis in AMC cultures.
Furthermore, results of the experiment dealing with effect of apoE3 and apoE4 on
neurogenesis in AMC neurons reveal a new feature of cortical neurogenesis - BrdUpositive satellite cells in the dendritic tree of approximately half of the studied adult
neurons in DNA synthesis phase.
(1) The results of the study on the isoform-specific cellular accumulation rate of

apoE over a time course of 1 hour in AMC neurons is consistent with the results of a
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previous study on the differential accumulation rate of apoE3 and apoE4 in Neuro-2a
neuroblastoma cell line. [22]. However, results of the present study reveal two new
significant features when compared to the study of apoE isoforms in neuroblastoma cell
line: (1) differential cell biology of apoE isoforms in adult brain model and (2) the pattern
of distribution of apoE isoforms in somata and dendrites of adult neurons.
The plasticity and functionality of the network of neurites in the adult brain
depends on the strength, health and branching of neurites and their capability to grow and
repair. Neurites, a term that cumulatively describes dendrites and an axon of a neuron, are
extensions of neuronal membrane, comprised of a thin double layer of fatty acids - one of
many molecules that are long chains of lipid-carboxylic acid found in fats and oils and in
cell membranes, as a component of phospholipids and glycolipids. The growth and
regeneration of the neurites depends on the supply of fatty acids and lipids to the neurons
[23, 24], where apoE plays a vital role as a transport lipoprotein that ensures the supply.
(2) Results of my study showed that apoE4 accumulated significantly slower in

AMC neurons than apoE3. Moreover, less apoE4 accumulates specifically in neurites
than apoE3. These data suggest that neurons that function in a system where apoE4 is
present do not have an adequate amount of lipid transporter reaching their neurites.
(3) The site where the difference in apoE3 and apoE4 binding takes place was

also determined. When HSPG receptor of LRP-HSPG receptor complex was removed no
binding or accumulation of either apoE3 and apoE4 occurred, which indicates that HSPG
plays a pivotal role in apoE isoforms uptake. Previous study [25] suggests that HSPG is a
'helper' receptor in the LRP-HSPG receptor complex, a ligand that allows LRP to
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internalize apoE isoforms, and that HSPG as a receptor by itself is less efficient than
LRP.
The results of my study show that inhibition of LRP significantly decreases apoE3
and apoE4 uptake, but does not abolish the difference in their uptake. This data suggests
that when the LRP receptor is blocked, the HSPG 'helper' receptor differentially
mediates apoE isoform uptake and at a lower rate, as previous study suggested [25]. The
differential binding of apoE3 and apoE4 to HSPG binding domain, rich with S04 groups
[26], may be due to differential amino acids at the position 112 in receptor binding
domain of apoE3 (cysteine) and apoE4 (arginine). The further study of cystein-S04
groups and arginine-S04 groups interactions may explain the basis for differential
binding of apoE3 and apoE4 to HSPG.
Differential accumulation rates of apoE3 and apoE4 shown in my study suggest
that the shortage of apoE, associated with apoE4, in neurons may be the basis of inhibited
neurite outgrowth in apoE neurons. Furthermore, lower concentrations of cellular apoE4
within the neurites may explain the stunned neurite outgrowth. The binding pattern at 5
minutes of incubation with apoE isoforms indicated that apoE receptors were distributed
through out the whole cell surface of neurites. The internalization pattern showed that
apoE isoforms movement inside the cell is directed toward somata with dense
accumulation of apoE vesicles in the somata after 60 minutes of incubation at 37°C.
However when comparing two isoforms, apoE4 was present at a much lower
concentration along the dendrites. Interestingly, significantly more apoE4 was bound to
neuronal surface than apoE3 after 60 minutes at 4°C, but no intracellular accumulation
occurred at this low temperature.
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What is the impact of shorter neurites in neuronal health and performance? The
shorter neurite outgrowth in apoE4 transgenic mice may be a cause of poorer neuronal
plasticity [27], performance [28] and regeneration after injury in apoE4 individuals [29],
as previous studies have shown. Based on the data of my study, I suggest that the
primary cause of shorter neurite outgrowth and consequently poorer neuronal circuitry
and ability to regenerate, associated with apoE4, may be a lesser amount of the lipid
transporter, apoE4, in adult neurons.
(4) However, the more important evidence for shorter neurite outgrowth in apoE4
neurons would be a smaller amount of fatty acid, a building block of neuronal membrane,
delivered to the neuron by apoE4. About two-thirds of brain is composed of fats. Fatty
acids, the simplest lipids, are just as important as vitamins and minerals, but unlike these
micronutrients that are required only in tiny amounts, fatty acids are needed in relatively
large quantities. Previous study has shown that incubation of ~-VLDL (very low density
lipoprotein) with apoE3 resulted in increased neurite outgrowth when compared with
incubation of ~-VLDL with apoE4 [22].
I predicted that apoE4 would deliver fewer lipids to neurons than apoE3 because
the rate of uptake of apoE4 was slower than apoE3 in neurons.

Investigation of

fluorescently labeled dodecanoic acid accumulation in live adult cortical neurons,
facilitated by apoE3, apoE4 or no apoE (KO) revealed that apoE3 delivers substantially
more fatty acid to neurons than apoE4. The smallest amount of fatty acid accumulated in
neurons in the absence of apoE (apoE KO), pointing to the previously established role of
apoE as a lipid transport protein [3]. Fluorescently labeled dodecanoic acid was used as a
lipid probe. It is a fluorescent fatty acid analog that has been used for lipid trafficking
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studies and as a general membrane probe. This analog has been tested before in several
studies and shown to undergo native-like transport and metabolism in cells [30]. Cells
cultured with apoE3 internalized approximately twice as much vesicular accumulations
of fluorescence as those with apoE4.

ApoE4 roughly doubled the amount of lipid

internalized compared to the absence of apoE (apoE KO). Therefore, although apoE4
was better than no apoE, it was much less effective than apoE3 in providing lipids. This
data suggests that smaller amounts of lipid associated with slower internalization of the
lipid transporter apoE4 may be a cause of shorter neurite outgrowth in adult neurons.
I propose the following model for the role of apoE4 in poor neuronal growth,
repair and regeneration possibly associated with development of AD: slower binding of
apoE4 results in fewer apoE4 in adult neurons and especially neurites; fewer apoE4
delivers fewer fatty acid required for neurite growth and repair, thus resulting in shorter
neurite outgrowth.
Preparation of adult culture strips cells of all processes. During the next three
days extensive neurite outgrowth occurs. Functional apoE supplies lipids for membrane
formation. In the absence of functional apoE, neuronal membrane formation is slowed.
Future studies on the agents that may increase apoE4 uptake and bring it to the level of
apoE3 may help improve neuronal growth and regeneration associated with apoE4.
(5) My next study shows that apoE isoforms also have differential effect on
neuronal environment - microglia. Microglial cells derive from hematopoietic stem cells,
share many properties with tissue macrophages and have important functions in neuronalglial network. In the normal brain, microglia is in a non-activated state and has branched
ciliated morphology. Microglia respond to damage or infection by proliferation and
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changing the morphology to macrophage-like phagocytic cells, which produce immune
response.
My study demonstrates that apoE regulates microglial proliferation and activation
in adult mouse cortical and adult mouse microglial cultures. Absence of apoE upregulated microglial activation and number in adult mouse models used in these
experiments. ApoE KO adult mouse cortical and microglial cultures had the highest
number of activated microglia and the highest iNOS level. ApoE4 treated cultures also
had numerous activated microglia and a higher level of iNOS. Only apoE3 treated
cultures had lower number of activated microglia and lower level of iNOS. ApoE3
treated adult cultures were represented by a large fraction of ciliated, process-bearing
non-activated microglia. Moreover, these data show that the differential effect of apoE
isoforms on microglial proliferation and activation is not facilitated by neuron-microglia
interactions, but is a result of direct effect of apoE on microglial biology.
These results are consistent with previous studies that show mice expressing apoE4
isoform have a greater N 0 production than mice expressing the apoE3 isoform [21, 31].
NO is generated following activation of NOS. There are three known NOS isoforms:
neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). iNOS is
not expressed in healthy tissue, but can be induced following various pathologic insults
including viral infection [32]. Previous study show that (1) nitric oxide associated with
elevated levels of iNOS had a neurodegenerative effect on rat substantia nigra
dopaminergic neurons, following LPS induction and (2) LPS-induced loss of
dopaminergic neurons was significantly inhibited by the administration of a selective
inhibitor of iNOS [33]. A study of the NO effects on differentiated neuroblastoma cell
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line Neuro2a, show that cell death and neurite retraction were partly reduced when NO
production was inhibited by nitric oxide synthase inhibitors; the study suggest that
inflammatory processes, which are partly transmitted via NO metabolites, may affect
neurite extension and thus may contribute to degenerative changes in Alzheimer's disease
[34].
Previous study on iNOS have also shown that, once translated, iNOS is
functionally active and produces NO for sustained periods of time and that neuronal
death following iNOS activation occurs slowly over time with the morphologic features
of apoptosis [32].
My present study shows that after 2 days of treatment, physiological levels (3 µg/ml)
of apoE4 up-regulated iNOS production nearly 2-fold in comparison to iNOS levels in
apoE3 treated adult cortical cultures, suggesting that inheritance of e4 allele may be a risk
factor for NO associated neurotoxicity in such individuals.
Results of previous studies show (1) a significant increase in amyloid plaques in the
AD patients with allele e4 of apoE and (2) that senile plaques in the AD patients are
surrounded by activated microglia and reactive astrocytes [11, 12, 13]. It has also been
reported that inflammatory responses by cytokines and oxygen free radicals such as nitric
oxide

(NO)

are

associated

with

amyloid

deposits

in

AD

brains.

A recent study investigated regional expression of iNOS and nNOS in the brains of
patients with dementia with Lewy bodies (DLB) compared with those of patients with
AD and non-demented elderly persons. In that study, overexpression of iNOS was
demonstrated in the amygdala, hippocampus, entorhinal and insular cortices of DLB
brains, the most vulnerable regions in DLB brains, as well as AD brains [35]. Glial
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involvement was also found around neuritic plaques and extracellular neurofibrillary
tangles [35].
Based on these recent findings and my present study, one would expect to find all of
the following in the AD brain of individuals with e4 allele: (1) amyloid plaques, (2)
extracellular neurofibrillary tangles, (3) smaller neurite extension, (4) elevated number of
activated microglia, surrounding plaques and tangles and (5) elevated levels of iNOS and
NO. However, the question now arises: are numerous activated microglia and elevated
iNOS and NO levels a consequence or a possible cause of neuropathology found in AD
brain?
Since three of the above mentioned hallmarks of apoE4-associated AD pathology
could be found in a healthy adult brain of an individual with e4 allele, I suggest that one
of the major AD risk factors could be the constant elevated number of activated microglia
and iNOS levels, which over years may have accumulated neurodegenerative effect and
lead to AD pathology.
Previous studies show that iNOS and NO levels are elevated even in the non-aged
adult animal transgenic models with e4 allele, before senile plagues and neurofibrillary
tangles could be detected in their brains [21]. My present study shows that physiological
levels of apoE4 can create a nearly 2-fold increase in iNOS levels in a non-aged adult
mouse cortical culture, in comparison to apoE3.
Another line of study, pointing to the role of activated microglia in pathology of AD,
shows that anti-inflammatory drugs could be a possible treatment for AD. Celastrol, a
plant-derived triterpene, decreased the induced expression of class II MHC molecules by
microglia and decreased induced NO production in macrophage lineage cells and
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endothelial cells [36]. Another study compared postmortem brain tissue from elderly,
nondemented, arthritic patients with a history of chronic nonsteroidal anti-inflammatory
drug (NSAID) use and nondemented control subjects with no history of arthritis or other
condition that might promote the regular use of NSAIDs. In both the NSAID-treated
group and control subjects, 59% of patients had some senile plaques, however NSAID
use was associated with less microglial activation [37]. These data shows that
suppression of microglial activation does not eliminate senile plagues in elderly
individuals, however, the role of microglial activation in senile plaque formation at a
younger age remains unclear and benefits of anti-inflammatory drugs in AD prevention
should be further studied.
Another study examined nitric oxide radical quenching activity of non-steroidal antiinflammatory drugs and steroidal drugs, using direct in vitro nitric oxide radical detecting
system by electron spin resonance spectrometry. The non-steroidal anti-inflammatory
drugs, aspirin, mefenamic acid, indomethacin and ketoprofen directly and dosedependently scavenged generated nitric oxide radicals. In experiments of nitric oxide
radical donor-induced neuronal damage, these four non-steroidal drugs significantly
prevented cell death and apoptotic nuclear changes in neurons [38].
Early detection methods of elevated iNOS or NO production .in the brain could be
useful biomarkers for detecting apoE4-associated risk for AD. In a recent study, plasma
and leukocytes were isolated from 48 sporadic AD and 23 healthy control subjects of
same age and sex. The results of that study demonstrate a significant reduction of TGFbetal levels in plasma of AD patients and significantly increased NOS activity in
leukocytes of AD patients [39].
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The results of my study clearly demonstrate that apoE4 induces microglial activation
and iNOS production by acting directly on microglia. I propose that elevated iNOS
levels, associated with microglial activation in apoE4 individuals may lead to long-term
neurotoxicity and, along with shorter neurite outgrowth associated with apoE4, present a
second major risk for developing AD. Further study of long-term effects of elevated
levels of iNOS and NO on neurons in young and mid-aged adults may give us an insight
on the extent to which microglial activation plays a role in AD pathology.
(6) Recently a substantial amount of evidence has emerged on the existence of
neurogenesis in the adult brain. These studies have shown proliferation of adult neurons
in adult hippocampus [40], dentate gyrus [41] and olfactory bulb [16].

Extent of

neurogenesis in adult brain and its role in a normal or injured brain is not yet fully
understood.
In the numerous AMC cultures established during my research, in the past two
years, neuronal proliferation was observed. However, the AMC culture is grown in
medium supplemented from 0 DIV with fibroblast growth factor (FGF) aiding in
recovery of neurons after culture preparation. Thus, neuronal proliferation may be
attributed to the presence of FGF and not to a naturally occurring event.
It was of interest to determine not only the mechanism of differential regulation of

neurite outgrowth by apoE3 and apoE4, but also whether apoE isoforms can regulate
neuronal proliferation in the absence ofFGF in the cell medium.
Assessment of total cell number in AMC culture treated with apoE3, apoE4 or no
apoE (apoE KO) at 4 DIV was performed by using tetrazolium salt (MTT cell
proliferation kit), which is cleaved to form a formazan dye by only metabolic active cells.
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The formazan dye concentration was then detected by ELISA. At 4 DIV there was no
significant difference in cell number between the treatments.
Since AMC cultures are comprised of three major cell types, it was still unclear
whether the number of neurons in apoE3, apoE4 or no apoE (apoE KO) treatments at 4
DIV was different. Based on the results of the effect of apoE3, apoE4 and no apoE (apoE
(KO) on microglial proliferation, results of cell proliferation detected by ELISA could
have represented various percentages of metabolically active cell types in each treatment.
Immunocytochemistry for neuron specific P-tubulin followed by the cell count in
each treatment showed a slightly higher number of neurons in the apoE3 group, followed
by apoE4 and then apoE KO (E3>E4>KO). However, the difference in cell number
between three groups at 4 DIV was not significant. Neurons are not fast regenerating
cells, which may explain why there was no significant difference in the number of
neurons between apoE3 or apoE4 treatment after 2 days of treatment.
Interestingly, no difference was observed in the total number of neurons per cover
slip when compared with previous AMC cultures, supplemented with FGF.
To account for the slight but non-significant difference in neuron number in
apoE3, apoE4 and no apoE (apoE KO) groups, double immunocytochemistry was
performed, anti-P-tubulin and BrdU, which allowed detection of neurons in the DNA
synthesis phase. Results of this experiment show (1) the presence of neurons in the DNA
synthesis phase in all three treatment groups, (2) approximately 20% of neurons in the
DNA synthesis phase in the apoE3 treatment of the total number of neurons treated, (3)
12% in apoE4 treatment and (4) 8% in apoE KO. The percentage of neurons in the DNA
synthesis phase in AMC culture treated with apoE3 and no FGF was significantly higher
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than such percentage in apoE4 and apoE KO treatments with no FGF. Of note, there was
no significant difference between apoE4 and apoE KO treatments.
These data show the evidence for neurogenesis in adult cultured cortical neurons
in the absence of growth factors and suggest that apoE plays a role in neurogenesis when
compared to no apoE (apoE KO). Furthermore, these data show that apoE3 is more
efficient than apoE4 in promoting neurogenesis in AMC culture by 4 DIV. The
experiment was performed between 0 and 4 DIV in order to avoid subjecting the cultures
to required medium change at 4 DIV. Repeating the experiment for 0-8 DIV may show
increased percentages of neurons in the DNA synthesis phase in each treatment.
It is an important finding that helps with better understand the possible roles of

apoE isoforms in aging or an injured brain and adds to the evidence of neurogenesis in
the adult brain.
Furthermore,

another novel finding

in this experiment was obtained.

Approximately half of the observed BrdU-positive neurons in apoE3, apoE4 and apoE
KO treatments exhibited BrdU-positive satellite cell phenomenon. Such phenomenon in
spinal ganglia was described previously [42, 43]. It has been shown that satellite cells
were young satellite glia, derived from glial progenitor cells.
In my experiments a single BrdU-positive satellite cell was located in the
dendritic tree, at the terminal bouton or at perikaryon of approximately half of BrdUpositive neurons in all three treatments. The satellite cell appeared to be of neuronal
origin due to the P-tubulin stain detected in satellite cell soma, which lack any membrane
extensions.

62

Previous study [42] has shown that the satellite cell - neuron relationship was
formed in spinal ganglia, where satellite cells were tightly connected with perikaryons of
some neuroblasts and young neurons. Further study on the role of satellite cells in the
dendritic tree or at perikaryon of adult neuron, where both cells are in a DNA synthesis
phase, may explain new mechanisms of adult neuronal proliferation.
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5. CONCLUSIONS

The aim of the several studies that make up my thesis research was to better
understand the mechanism and role of apoE4 in the neuronal environment - in adult
mouse cortical culture model. These studies investigated various aspects of membrane,
intracellular, and extracellular biology of apoE4 and found five major avenues by which
apoE4 may lead to a neurodegenerarative diseases, such as AD.
Before I present a summary of the above discussed results, which compare apoE3
and apoE4 functions in adult cortical cultures, I would like to emphasize the importance
of apoE to neuronal health regardless of its isoforms, based on the results obtained from
the apoE KO group in several studies that comprise my thesis research.
Results show that in the absence of apoE (apoE KO) in AMC culture: (1) neurons
are supplied with the lowest amount of lipid, (2) microglia are predominantly (-80%)
macrophage-like and fast-proliferating, (3) high level of iNOS is present due to the large
number of activated microglia and (4) neurons proliferate slowly; when all of the four
outcomes are compared with the presence of either apoE3 or apoE4.

These results

clearly show that apoE isoforms regulate very important cellular events and play a vital
role in adult neuronal biology.
When I compared several functions and mechanisms of apoE3 and apoE4, I found
that although the presence of apoE4 is slightly more beneficial to neuronal environment
than no apoE, it is far less efficient than the presence of apoE3. When compared to
apoE3, apoE4 (1) has slower binding and accumulation rate in adult neurons, (2) delivers
fewer lipid to adult neurons and especially neurites, (3) induces microglial activation,
proliferation and iNOS production and (4) does not promote neurogenesis. All of these
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properties of apoE4, when compared to apoE3, may not lead to acute neuro-degeneration
in a young or mid-aged individual with e4 allele(s). However, the long-term accumulated
effect may present an accountable risk to aged neurons at the age of 65 and older,
resulting in progressive neuronal tissue loss and dementia, found in Alzheimer's disease.
Finding agents that may improve apoE4 functions in adult neurons and increase it's
efficiency to match the efficiency of apoE3 may better protect aged neurons from
deterioration.
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